U-Chart Analysis:Kubota Pharmaceutical Holdings Co.,Ltd.:4596

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Kubota Pharmaceutical Holdings Co.,Ltd. Go to web site 4596 Medicals 東証グロース December 1, 2000 2016.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Kubota Pharmaceutical Holdings Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kubota Pharmaceutical Holdings Co.,Ltd. Balance Sheet 2023年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Balance Sheet 2022年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Balance Sheet 2021年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Balance Sheet 2020年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents 2,768 4,049 3,977 2,534 4,192
Other Current AssetsHelp 102 133 648 3,883 3,985
Tangible Fixed AssetsHelp 129 204 192 220 53
Intangible Fixed AssetHelp 0 0 0 0 563
Investments and OthersHelp 18 34 15 55 -53
Total AssetsHelp 3,017 4,420 4,833 6,692 8,741
Total Current LiabilitiesHelp 283 361 542 519 523
Total Long-term LiabilitiesHelp 87 109 137 180 140
Shareholder's EquityHelp 2,647 3,950 4,153 5,993 8,077
Total LiabilitiesHelp 3,017 4,420 4,833 6,692 8,741

Kubota Pharmaceutical Holdings Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kubota Pharmaceutical Holdings Co.,Ltd. Profit and Loss Account 2023年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Profit and Loss Account 2022年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Profit and Loss Account 2021年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Profit and Loss Account 2020年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales 40 8 0 38 0
Total Sales 40 8 0 38 0
Cost of SalesHelp - 12 6 6 -
Other Costs and RevenueHelp 1,529 2,012 2,611 2,469 3,066
Total CostsHelp 1,529 2,024 2,616 2,475 3,066
Net RevenueHelp - -4 -6 32 -
Earnings Before TaxHelp -1,490 -2,016 -2,616 -2,437 -3,105
Net IncomeHelp -1,490 -2,016 -2,616 -2,437 -3,066
Net Income -1,490 -2,016 -2,616 -2,437 -3,066

Kubota Pharmaceutical Holdings Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kubota Pharmaceutical Holdings Co.,Ltd. Cash Flow Statement 2023年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Cash Flow Statement 2022年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Cash Flow Statement 2021年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Cash Flow Statement 2020年12月期 Kubota Pharmaceutical Holdings Co.,Ltd. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help -1,336 -2,087 -2,514 -2,249 -3,418
Investing Cash Flow(ICF)Help -45 505 3,563 340 4,594
Financing Cash FlowHelp 97 1,447 171 454 463
Exchange Difference of Cash and Cash EquivalentsHelp 3 206 223 -204 -31
Net Increase and Decrease in Cash and Cash Equivalentsn -1,281 72 1,444 -1,659 1,607

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Kubota Pharmaceutical Holdings Co.,Ltd.

Company where related level is highHelp

JCR Pharmaceuticals Co.,Ltd.
SAWAI PHARMACEUTICAL CO.,LTD.
Nxera Pharma Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Modalis Therapeutics Corporation
BrightPath Biotherapeutics Co., Ltd.
Kringle Pharma,Inc.
SAWAI GROUP HOLDINGS Co., Ltd.
TORII PHARMACEUTICAL CO.,LTD.
ZERIA PHARMACEUTICAL CO.,LTD.